In both iCCA and eCCA, the 5-year overall survival rate was significantly lower in EGFR-positive patients than that in EGFR-negative patients, indicating that EGFR overexpression is an independent poor prognostic factor in CCA. The gene discussed is EGFR; the disease is cholangiocarcinoma.